Technical420 Site Search

The marijuana industry is a very fragmented and each state has their own set of laws and regulations. These differences make it tough for analysts to accurately forecast growth and they must model each state differently.  One of the most important factors analysts consider when trying to determine the size…

Democratic Senators Jeff Merkley and Ron Wyden and Representative Earl Blumenauer are urging Congress to pass legislation that would give legal marijuana businesses access to banking services. The lawmakers made their announcement at the Rivermark Community Credit Union in Portland.Many cannabis companies are having a tough time opening a bank…

On Saturday, more than 8,000 people attended the Hanfparade march (hemp parade) in Berlin. The participants demanded the legalization of cannabis for medical uses, alternative energy, and recreational consumption. They were joined by a number of Green Party politicians.Prohibition is costly and ineffective In May, Joachim Pfeiffer, a member of Chancellor Angela…

GW Pharmaceuticals (GWPH) and Insys Therapeutics, Inc. (INSY) reported third-quarter financial results this morning and the companies have seen opposite reactions from the market.Shares of GWPH rallied 4% off of the open, while INSY plummeted 11%. INSY has rallied off of its lows but we see further weakness ahead. Let’s highlight the results…

Yesterday, Chuck Rosenberg, who is the new head of the Drug Enforcement Agency (DEA), made the following statement at the agency’s headquarters.  “Heroin is clearly more dangerous than marijuana.”Last week, Rosenberg said marijuana is probably not as dangerous as heroin and the press had a field day over his statement.…

The American Psychological Association recently released the results of a study which should alleviate some fears expressed by anti-marijuana groups and doctors. The purpose of the study was to determine if teens who use marijuana suffer from long-term health consequences.Researchers from the University of Pittsburgh Medical Center and Rutgers University…

There have been a number of questions raised about Zynerba Pharmaceuticals’ upcoming inital public offering (IPO) to which I would like to address. Tomorrow, ZYNE will commence trading on the NASDAQ exchange and they will issue 3,000,000 shares which will be priced tonight.Zynerba is looking to raise $36.3 million at a…

Investors, it is time to set aside some cash! On Wednesday, Zynerba Pharmaceuticals, Inc. (ZYNE) will have its initial public offering (IPO) on the NASDAQ exchange. Zynerba will issue 3,000,000 shares and they will be offered in the $13.00-$15.00 range. The total offering amount is $51.75 million (total expenses are…